NINTH AMENDMENT TO LOAN AND SECURITY AGREEMENTLoan and Security Agreement • November 29th, 2018 • Meridian Bioscience Inc • In vitro & in vivo diagnostic substances
Contract Type FiledNovember 29th, 2018 Company IndustryThis Ninth Amendment to the Loan and Security Agreement (the “Amendment”) is entered into as of September 24, 2018, by and among Fifth Third Bank, an Ohio banking corporation (the “Bank”) and Meridian Bioscience, Inc., an Ohio corporation (“Parent” or “Agent”), Meridian Bioscience Corporation, an Ohio corporation (“Corp.”), Omega Technologies, Inc., an Ohio corporation (“Omega”), Meridian Life Science, Inc., a Maine corporation (“MLS”) and Bioline USA, Inc., a Massachusetts corporation (“Bio”) (collectively, the “Borrowers” and individually a “Borrower”).